HCSGD entry for CXCL16
1. General information
| Official gene symbol | CXCL16 |
|---|---|
| Entrez ID | 58191 |
| Gene full name | chemokine (C-X-C motif) ligand 16 |
| Other gene symbols | CXCLG16 SR-PSOX SRPSOX |
| Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
|---|---|---|---|
| GO:0005041 | Low-density lipoprotein receptor activity | IEA ISS | molecular_function |
| GO:0005044 | Scavenger receptor activity | IEA TAS | molecular_function |
| GO:0005102 | Receptor binding | NAS | molecular_function |
| GO:0005576 | Extracellular region | NAS TAS | cellular_component |
| GO:0005615 | Extracellular space | IDA | cellular_component |
| GO:0005886 | Plasma membrane | IEA | cellular_component |
| GO:0006898 | Receptor-mediated endocytosis | NAS | biological_process |
| GO:0006935 | Chemotaxis | NAS | biological_process |
| GO:0008009 | Chemokine activity | IDA IEA ISS | molecular_function |
| GO:0016020 | Membrane | TAS | cellular_component |
| GO:0016021 | Integral component of membrane | NAS | cellular_component |
| GO:0030307 | Positive regulation of cell growth | IEA IMP | biological_process |
| GO:0030335 | Positive regulation of cell migration | IEA IMP | biological_process |
| GO:0034097 | Response to cytokine | IDA | biological_process |
| GO:0034341 | Response to interferon-gamma | IDA IEA | biological_process |
| GO:0034612 | Response to tumor necrosis factor | IDA IEA | biological_process |
| GO:0048247 | Lymphocyte chemotaxis | IEA NAS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
| p-value up | p-value down | FDR up | FDR down |
|---|---|---|---|
| 0.0940845713 | 0.1953613123 | 0.6428087701 | 0.8564465523 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
| Data source | Up or down | Log fold change |
|---|---|---|
| GSE11954 | Down | -0.0544142290 |
| GSE13712_SHEAR | Up | 0.2396014350 |
| GSE13712_STATIC | Up | 0.4303919981 |
| GSE19018 | Up | 0.0672315244 |
| GSE19899_A1 | Up | 0.1300967507 |
| GSE19899_A2 | Up | 0.1558312748 |
| PubMed_21979375_A1 | Up | 0.5722652641 |
| PubMed_21979375_A2 | Up | 0.0354356902 |
| GSE35957 | Down | -1.5705567745 |
| GSE36640 | Up | 0.5084267774 |
| GSE54402 | Down | -0.4236913291 |
| GSE9593 | Down | -1.8580325355 |
| GSE43922 | Up | 0.0137500677 |
| GSE24585 | Down | -0.0366032918 |
| GSE37065 | Up | 0.7325937805 |
| GSE28863_A1 | Up | 0.3113611391 |
| GSE28863_A2 | Up | 0.1631053351 |
| GSE28863_A3 | Up | 0.3751357068 |
| GSE28863_A4 | Down | -0.1741173292 |
| GSE48662 | Up | 0.5725740090 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
|---|---|---|---|---|---|
| hsa-miR-335-5p | MIMAT0000765 | MIRT019098 | Microarray | Functional MTI (Weak) | 18185580 |
| hsa-miR-744-5p | MIMAT0004945 | MIRT037621 | CLASH | Functional MTI (Weak) | 23622248 |
| hsa-miR-92a-3p | MIMAT0000092 | MIRT049831 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 1 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
|---|---|
| 26272362 | The chemokine CXCL16 and its receptor, C-X-C chemokine receptor (CXCR6), affect tumor progression through different pathways, including leukocyte recruitment and function, cellular senescence, tumor cell proliferation, survival, invasion, and metastasis |
| 26272362 | We examined how the expression of CXCL16/CXCR6 in prostate cancer (PC) was related to clinicopathological features and activation of inflammatory cells |
| 26272362 | Immunohistochemistry was used to evaluate the expression of CXCL16/CXCR6, CD3(+) T cells (CD4(+), CD8(+)), and CD20(+) B cells |
| 26272362 | High expression levels of CXCL16 [hazard ratio (HR), 2 |
| 26272362 | As a conclusion, high protein expression of CXCL16 and high protein co-expression of CXCL16/CXCR6 in PC were independent predictors for a worse clinical outcome |
Entries Per Page
Displaying Page of

